International Myeloma Foundation

International Myeloma Foundation
source
Name	International Myeloma Foundation
Abbreviation	IMF
Formation	1990
Founder	Brian Druker; Jerry and Kay Helms
Type	Nonprofit organization
Headquarters	Northbrook, Illinois
Region served	Worldwide
Leader title	Chairman
Leader name	Brian G.M. Durie

International Myeloma Foundation is a nonprofit organization focused on multiple myeloma research, patient support, and professional education. It engages clinicians, scientists, patients, and policymakers to accelerate therapies and improve outcomes across global health systems. The foundation operates programs that intersect clinical trials, translational science, patient advocacy, and biomedical philanthropy.

History

The foundation emerged in the context of pioneering cancer organizations such as American Cancer Society, Leukemia & Lymphoma Society, Stand Up To Cancer, Susan G. Komen, and Dana-Farber Cancer Institute and was shaped by influences from institutions like Mayo Clinic, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and Johns Hopkins Hospital. Early collaborations mirrored models used by Fred Hutchinson Cancer Research Center, Cleveland Clinic, UCLA Health, and Stanford Health Care. Initial leadership drew on clinicians connected to University of California, San Francisco, University of Pennsylvania Health System, Georgetown University Medical Center, and University of Texas Southwestern Medical Center. Key moments paralleled advances at National Institutes of Health, Food and Drug Administration, European Medicines Agency, and academic consortia including Alliance for Clinical Trials in Oncology and Children's Oncology Group. The organization’s evolution reflects the trajectories of patient advocacy groups such as Michael J. Fox Foundation, Cystic Fibrosis Foundation, Alzheimer's Association, and March of Dimes.

Mission and Programs

The foundation’s mission aligns with objectives seen at World Health Organization, Bill & Melinda Gates Foundation, American Society of Hematology, European Hematology Association, and American Society of Clinical Oncology to reduce disease burden through research, education, and advocacy. Programs include patient education sessions modeled after initiatives at Memorial Sloan Kettering Cancer Center, professional symposia similar to ASCO Annual Meeting, and regional outreach comparable to American Cancer Society Hope Lodge and Cancer Research UK events. The organization runs clinical education, training, and fellowship schemes that parallel offerings at Harvard Medical School, Yale School of Medicine, Columbia University Irving Medical Center, and King's College London.

Research and Funding Initiatives

Research funding mechanisms mirror grantmaking strategies used by National Cancer Institute, European Research Council, Wellcome Trust, Howard Hughes Medical Institute, and Simons Foundation. The foundation supports translational programs aligned with studies at Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Sloan Kettering Institute, Broad Institute, and Cold Spring Harbor Laboratory. It has endorsed biomarker discovery akin to efforts at Cancer Research UK Cambridge Institute, proteomics collaborations like those at European Molecular Biology Laboratory, and genomics projects resonant with The Cancer Genome Atlas and 1000 Genomes Project. Funding initiatives include pilot grants, fellowship awards, and support for investigator-initiated trials similar to structures at Cancer Research Institute and American Association for Cancer Research.

Patient and Community Services

Services reflect models from Patient Advocate Foundation, National Comprehensive Cancer Network, Macmillan Cancer Support, and Canadian Cancer Society with helplines, educational literature, and peer support networks. Programs include survivorship planning resembling Livestrong Foundation efforts, caregiver resources paralleling Family Caregiver Alliance, and nutritional guidance akin to offerings from Mayo Clinic. Support extends to global patient registries comparable to SEER Program and patient-reported outcomes initiatives like those at PROMIS and PCORI.

Advocacy and Public Policy

Advocacy work interacts with regulatory and policy institutions such as United States Congress, European Parliament, National Institutes of Health, Food and Drug Administration, and Centers for Medicare & Medicaid Services. The foundation engages in access campaigns similar to actions by Global Fund to Fight AIDS, Tuberculosis and Malaria, Doctors Without Borders, American Medical Association, and Patient-Centered Outcomes Research Institute to influence reimbursement, orphan drug designation, and drug approval pathways. Policy initiatives reflect lobbying and coalition-building seen with PhRMA, BIO (trade association), Health Care Without Harm, and World Bank health financing dialogues.

Organizational Structure and Governance

Governance mirrors nonprofit best practices from institutions like United Nations Foundation, Ford Foundation, Rockefeller Foundation, Gates Cambridge Trust, and Wellcome Trust. The board includes clinicians, scientists, and patient advocates similar to leadership at St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, Sloan Kettering Cancer Center, and Institut Curie. Executive management uses models from Kaiser Permanente, Cleveland Clinic, Geisinger Health System, and Montefiore Medical Center to coordinate global programs, compliance, and fundraising activities akin to those at Red Cross societies.

Partnerships and Collaborations

Collaborations span academic centers such as University of Oxford, University of Cambridge, Imperial College London, Karolinska Institutet, and University of Tokyo; research networks like European Organisation for Research and Treatment of Cancer, International Clinical Trials Network, and Translational Medicine Network; and industry partners akin to Roche, Novartis, Pfizer, Bristol-Myers Squibb, and Takeda. The foundation participates in consortia comparable to Clinical Trials Transformation Initiative, public-private partnerships like Accelerating Medicines Partnership, and philanthropic coalitions such as Wellcome Trust initiatives.

Category:Medical research foundations